Monthly Archives: March 2014

Meet the Cyborg Teaching Musicians How to Play Color, Not Sheet Music

Posted on by

Neil Harbisson is a colorblind artist who conducted the first concert using colors instead of notes. Here, he's capturing the colors of Barcelona's Palau de la Musica, the concert's venue, which he then translated into a musical score. Image: Vodafone

Neil Harbisson is a colorblind artist who conducted the first concert using colors instead of notes. Here, he's capturing the colors of Barcelona's Palau de la Musica, the concert's venue, which he then translated into a musical score.

Harbisson, who listens to colors through an eyeborg implanted in his skull, taught a youth choir and quartet how to translate colors into notes. Each color we see has a frequency that emits a high-pitched note. Image: Vodafone

Harbisson, who listens to colors through an eyeborg implanted in his skull, taught a youth choir and quartet how to translate colors into notes. Each color we see has a frequency that emits a high-pitched note.

During the concert, Harbisson played conductor/light technician, changing the colors on stage to prompt the musicians to change notes. Image: Vodafone

During the concert, Harbisson played conductor/light technician, changing the colors on stage to prompt the musicians to change notes.

Harbisson with his eyeborg. Image: Vodafone

Harbisson with his eyeborg.

Neil Harbisson is a colorblind artist who conducted the first concert using colors instead of notes. Here, he's capturing the colors of Barcelona's Palau de la Musica, the concert's venue, which he then translated into a musical score. Image: Vodafone

Neil Harbisson is a colorblind artist who conducted the first concert using colors instead of notes. Here, he's capturing the colors of Barcelona's Palau de la Musica, the concert's venue, which he then translated into a musical score.

See the rest here:

Meet the Cyborg Teaching Musicians How to Play Color, Not Sheet Music

MMAjunkie Radio (noon ET): 'Cyborg,' Carl, Moraes, Whiteford, Marshman, Hill

Posted on by

MMAjunkie Radio today welcomes to the show Cristiane Justino, Steve Carl,Marlon Moraes, Robert Whiteford, Jack Marshmanand Dave Hill.

In addition, well give away tickets to WSOF 9 and Bellator 114.

Cyborg visits the boys in the studio. On Friday, she co-headlines Lion Fight 14 in Las Vegas. Carl defends his welterweight title on Saturday at WSOF 9 in Las Vegas against Rousimar Palhares. Moraes fights for the inaugural WSOF bantamweight title against Josh Rettinghouse on Friday. Whiteford will take about his recent UFC 171 victory. And Marshman and Hill fight at Cage Warriors Fight Night 10 on Saturday.

MMAjunkie Radio airs today from noon to 2 p.m. ET (9 to 11 a.m. PT), live from Mandalay Bay Resort & Casino in Las Vegas. Listen to and watch a video stream of the three-hour show at http://www.mmajunkie.com/radio, or watch it live on select television markets as part of Fight Now TV.

MMAjunkie.com Radio listener guide:

Here is the original post:

MMAjunkie Radio (noon ET): 'Cyborg,' Carl, Moraes, Whiteford, Marshman, Hill

Arnold Schwarzenegger Says His Cyborg Ages in 'Terminator: Genesis'

Posted on by

March 26, 2014 06:02:24 GMT The 'Sabotage' actor explains that the robot he returns to play in the Alan Taylor-directed movie will age.

explains how he will return to play a supposedly-never-aging robot in "". In a chat with MTV News, the actor says that his older appearance makes sense because the cyborg in this franchise will age.

"The way that the character is written, it's a machine underneath," the 66-year-old star explains. "It's this metal skeleton. But above that is human flesh. And the Terminator's flesh ages, just like any other human being's flesh. Maybe not as fast. But it definitely ages."

He spills more beans, "Terminator deals a lot with time travel, so there will be a younger T-800 and then what that model does later on when it gets reprogrammed, and who gets a hold of him. So it will be all kinds of interesting twists in the movie, but I feel so good."

"It will be challenging," the former Governor of California adds, "because it will be a new director, and it will be a really action packed movie. And sometimes it does get more difficult when you're 66 years old and doing this kind of action, versus when you're in your 30s or in your 40s."

Fresh of his directing gig in "", Alan Taylor is tapped to helm the new "Terminator" movie. will play Sarah Connor, will star as her son John, and will portray his father Kylie. It will arrive Stateside on July 1, 2015.

In a previous interview with Collider, Schwarzenegger said the movie would have the same feel as "Terminator 2". He explained, "There's hardcore action and it has some really great visual effects in there, but not over the top. It's not a Thor type of movie, even though it's the same director. It has good special effects, but just enough to say, 'Wow, where did that come from? How did they do that?' "

A new casting report mentions "" star John Boyega who is in talks for "" is also eyed for an important role in "Terminator: Genesis". Rumor has it, he is a contender to play the son of Miles Dyson who was the man responsible for the creation of Skynet. Dyson was played by Joe Morton in the previous film.

AceShowbiz.com

View post:

Arnold Schwarzenegger Says His Cyborg Ages in 'Terminator: Genesis'

@CNN @ErinBurnett misguided errounous comments about Panama Beaches apr 20th, 2014 – Video

Posted on by


@CNN @ErinBurnett misguided errounous comments about Panama Beaches apr 20th, 2014
View Panamenian beaches here: https://www.michantin.com/?p=3165 This is CNN anchor Erin Burnett talking about a beach in Panama on a totally unrelated topic ...

By: Anel Salas

View original post here:

@CNN @ErinBurnett misguided errounous comments about Panama Beaches apr 20th, 2014 - Video

Beaches Jazz Festival supporter launches petition to save funding

Posted on by

ABOVE: Beaches Jazz Festival organizer launches petition to save funding. Carey Marsden reports.

This post has been updated to properly identify the individual behind the petition as a festival organizer.

TORONTO A Beaches Jazz Festival organizer has launched an online petitionto urge Ontario premier Kathleen Wynne to restore funding to the free summer event after its request for a $120,000 grant was rejected.

The festival, which attracted an estimated 500,000 people last year, received $75,000 from the Celebrate Ontario program in each of the last six years.

Organizers were told on March 13 that they would no longer receive the funding this time around.

This year, the festival is in danger of being drastically reduced in size and scope, reads the petition, posted at change.org by Joanna Katchutas, the festivals Multi-Arts and Photography program coordinator.

Critics argued the move seemed odd as the governing Liberals awarded a $300,000 grant to multimillionaire rap star Drake to stage his two-day OVO Fest in Toronto this summer.

BELOW: The Beaches Jazz Festival has been denied a provincial grant it has received in the past. Carey Marsden reports on March 20.

Tourism Minister Michael Chan defended the decision on Monday, saying Celebrate Ontario is a competitive program, which attracted 441 applications last year, and supports many events across the province.

Unfortunately this year, the jazz festival, the proposal they submitted they were not able to make it, he said.

Read more:

Beaches Jazz Festival supporter launches petition to save funding

RVCC astronomy educator chosen for NASA research flight

Posted on by

Theresa Moody from the New Jersey Astronomy Center (NJACE) at Raritan Valley Community College has been selected for a special NASA program for educators. The Astronomy Educator/Program Manager will participate in NASA's Stratospheric Observatory for Infrared Astronomy (SOFIA), which will become a flying classroom for educators in the next few months.

As a SOFIA Airborne Astronomy Ambassador, the High Bridge resident will join one of 12 two-person teams representing educators from 10 states. Each will be paired with a professional astronomer to observe first-hand how airborne infrared astronomy is conducted. After their flight opportunities, Airborne Astronomy Ambassadors will take what they learn back to their classrooms and into their communities to promote science literacy.

SOFIA is a highly modified Boeing 747SP jetliner fitted with a 100-inch (2.5-meter) effective diameter telescope. The aircraft flies at altitudes between 39,000 and 45,000 feet (12-14 kilometers), above the water vapor in the Earths atmosphere, and collects data in the infrared spectrum.

Moody and her teacher partner, Margaret Holzer of Chatham High School, will participate in the SOFIA flight during the week of May 10-17. Holzer and Moody will co-design a variety of investigations on Light and the Electromagnetic Spectrum. These investigations will be designed to integrate the new Science and Engineering Practices as described in Next Generation Science Standards and will draw on existing NASA resources and investigations. Once designed, Holzer will implement these new investigations into her high school classroom and Moody will include them in workshops offered at NJACE's Science Education Institute.

SOFIA offers educator teams unprecedented access to infrared astronomers and the unique capabilities of an airborne observatory, said John Gagosian, SOFIA program executive at NASA Headquarters in Washington. Previous Airborne Astronomy Ambassadors teams have witnessed SOFIA's world-class astronomical science and have used this experience in hundreds of science, technology, engineering and math teaching opportunities throughout the United States.

Educators are selected through a rigorous peer-reviewed process for this yearly professional development opportunity, said astronomer Dana Backman, manager of SOFIA's education and public outreach programs at NASA's Ames Research Center in Moffett Field, CA. To date, the Airborne Astronomy Ambassadors program has flown 15 teams totaling 31 educators from 17 states, and we look forward to working with this new cadre of educators as they take NASA science into their communities.

As the program manager of the NJACE Science Education Institute, Theresa Moody has been designing and co-facilitating teacher professional development workshops at RVCC since 2006. She also has more than seven years of experience teaching physical science and astronomy at an inner-city high school in Bridgeport, Conn. She has facilitated trainings both nationally and internationally, including the Queen Rania Teaching Academy in Amman, Jordan. She is also an active volunteer, qualified observer and Board member of the New Jersey Astronomical Association, where she leads monthly Young Astronomer programs for children.

The New Jersey Astronomy Center for Education (NJACE) includes a 100-seat Planetarium and the Science Education Institute. The Science Education Institute offers high quality customized professional development programs for school districts, ranging from one-day workshops to long-term partnership programs. This year, NJACE provided 14 different science workshops on the RVCC campus, including programs for K-12 teachers, museum providers, amateur astronomers and college educators. In addition, NJACE provides consulting services to numerous districts and other educational organizations. For more information, visit raritanval.edu/njace.

SOFIA is a joint project of NASA and the German Aerospace Center (DLR). The aircraft is based at the Dryden Aircraft Operations Facility in Palmdale, CA. NASA's Dryden Flight Research Center in Edwards, CA, manages the program. Ames Research Center manages the SOFIA science and mission operations in cooperation with the Universities Space Research Association (USRA) in Columbia, MD, and the German SOFIA Institute (DSI) at the University of Stuttgart.

For additional information about SOFIA, visit nasa.gov/sofia or dlr.de/en/sofia. To learn more about SOFIA's science mission and scientific instruments, visit sofia.usra.edu and dsi.uni-stuttgart.de/index.en.html.

Visit link:

RVCC astronomy educator chosen for NASA research flight

UofSC's McNair Center partners with Fokker Technologies for aerospace research

Posted on by

PUBLIC RELEASE DATE:

25-Mar-2014

Contact: Jeff Stensland stenslan@mailbox.sc.edu 803-777-3686 University of South Carolina

COLUMBIA, S.CThe Ronald E. McNair Center for Aerospace Innovation and Research, a University of South Carolina center, announced a formal research partnership with Fokker Aerostructures, a subsidiary of Dutch-based Fokker Technologies, to support and inspire their development of next-generation aircraft technology.

The multi-year research agreement establishes a framework to collaborate on projects that meet the needs of Fokker Aerostructures and its customers. Specific project details are being finalized, and likely will involve the development of advanced manufacturing technology for thermoplastic composites, using Digital Image Correlation to better understand failure mechanisms and certification strategies for the use of new advanced composite structures.

Fokker is a leading global aerospace specialist that delivers smart, integrated, economic solutions that offer technology benefits in terms of cost, weight and availability. This is the company's first partnership with an American university research center.

The McNair Center, which opened in 2011, has 27 contributing researchers working in a wide range of aerospace related research fields. The goal of the partnership is to develop and commercialize new technology, processes and methods and take products to market through licensing agreements.

Richard Cobben, vice president technology and Rob Kruithof, director of global Engineering for Fokker Aerostructures, say two things attracted the company to McNairgeography and existing research expertise.

"South Carolina is an interesting environment because there are so many aeronautics companies located nearby, such as Gulfstream, Boeing, Lockheed Martin, Cessna and Honda jet, and many of their suppliers. McNair is situated in the center of all of that activity," Cobben said. "Although the McNair Center is new, it's clear that they bring to the table a lot of experience in different fields. We're always looking to find the best knowledge networksthat's our lifeline."

In addition to the research agreement, Fokker Aerostructures will join the McNair Center's Strategic Advisory Board, which is chartered to help build and validate McNair's future research roadmaps.

Read more here:

UofSC's McNair Center partners with Fokker Technologies for aerospace research

Nanomedicine Research

Posted on by

Nanomedicine is the medical application of nanotechnology that will hopefully lead to useful research tools, advanced drug delivery systems, and new ways to treat disease or repair damaged tissues and cells. Drug delivery is currently the most advanced application of nanotechnology in medicine. Nanoscale particles are being developed to improve drug bioavailability, a major limitation in the design of new drugs. Poor bioavailability is especially problematic with newer and still experimental RNA interference therapy. Lipid or polymer-based nanoparticles are taken up by cells due to their small size, rather than being cleared from the body. These nanoparticles can be used to shuttle drugs into cells which may not have accepted the drug on its own. The nanoparticle chaperone may also be able to specifically target certain cell types, possibly reducing toxicity and improving efficacy. Nanoparticles such as quantum dot nanocrystals are the size of a protein molecule or short stretch of DNA. Quantum dots can be engineered to absorb and emit many wavelengths of light with very sharp precision. This makes them ideal for protein-protein interaction studies as they can be linked to molecules to form long-lived probes. They can track biological events by tagging specific proteins or DNA in order to follow their progress through biological pathways. In medicine, quantum dots could be used for diagnostic purposes. Dendrimers are another interesting and powerful use of nanotechnology in medicine. Dendrimers are nanostructured synthetic molecules with a regular branching structure projecting from a central core. Dendrimers form one layer at a time so the size of the dendrimer is determined by the number of synthetic steps. Each dendrimer is usually only a few nanometers wide. The outside layer can be engineered to be composed of specific functional groups that can act as hooks to specifically bind other molecules such as DNA. Dendrimers may act as effective agents for delivering DNA into cells during gene therapy. While viral vectors typically trigger an immune response, in principle, dendrimers should not. Nanorobotics or molecular nanotechnology involves the creation of complex mechanical systems constructed from the molecular level. Richard Feynman was the first to propose using machine tools to make smaller machine tools which can make smaller machine tools down to the atomic level. DNA makes an ideal material for the construction of nanomachines due to its stiffness. The intermolecular interactions of DNA are well-known and can be easily predicted. The self-assembly of DNA further facilitates its use as a construction material. Dr. Nadrian Seeman pioneered the use of DNA as a construction material and can make virtually any regular 3D shape. In 1999 his group succeeded in building the first nanoscale robotic actuator from DNA. DNA and later, nanotubes, have been used to construct molecular tweezers which can be used to physically manipulate nanostructures. Research into the construction of nanomotors has advanced greatly and nanomotors will form an important part of future nanorobots. Carlo Montemagno at Cornell has mutated the central rotating shaft of ATPase to have metal-binding amino acids that allow the ATPase to bind to nanoscale nickel pedestals. A silicon bar 100 nanometers long was bound to the rotor subunit of each ATPase by self-assembly, creating an ATP-powered molecular motor. These nanorobots may eventually form sophisticated cellular factories, used to synthesize drugs, repair damaged DNA, and releasing drugs on command.

View post:
Nanomedicine Research

Stem cell trials on tackling osteoarthritis may lead to treatment in five years

Posted on by

The trials involve injecting adult stem cells derived from adipose tissue or fat into cartilage to stimulate its regeneration

Researchers in Galway predict that stem cells could be used to treat osteoarthritis within five years, following successful initial clinical trials.

The trials involve injecting adult stem cells derived from adipose tissue or fat into cartilage to stimulate its regeneration.

Osteoarthritis affects some 70 million people across the EU, and current treatment is limited to surgery or pain management.

Some 400,000 people in Ireland are affected by this most common form of human arthritis, which is characterised by the often very painful degeneration of cartilage in joints.

Successful trial NUI Galway (NUIG) scientists, who are part of a 9 million EU-funded project, have just finished the successful phase one clinical trial.

Prof Frank Barry, scientific director of NUIGs Regenerative Medicine Institute (Remedi), yesterday said the positive early results indicate a treatment was in sight.

From the clinical trials conducted so far, we have seen the first signs of finding a cure for this truly incapacitating disease which affects so many, Prof Barry said. Using the patients own stem cells we have been able to treat their diseased joints, and relieve their suffering and burden of pain.

Whilst we are still in the early stages of clinical trials, the results so far are extremely positive such that the use of stem cell therapy for osteoarthritis could become a reality for patients within the next five years, he said.

Adipose stem cells Stem cells can be harvested in large quantities from adipose tissue or fat, with minimally invasive surgery. These cells have emerged in recent years as a good alternative to stem cells derived from bone marrow, Prof Barry notes.

Read more from the original source:
Stem cell trials on tackling osteoarthritis may lead to treatment in five years

Stem Cell-Derived Beta Cells Under Skin Replace Insulin

Posted on by

Contact Information

Available for logged-in reporters only

Newswise Scientists at University of California, San Diego School of Medicine and Sanford-Burnham Medical Research Institute have shown that by encapsulating immature pancreatic cells derived from human embryonic stem cells (hESC), and implanting them under the skin of diabetic mouse models, sufficient insulin is produced to maintain glucose levels without unwanted potential trade-offs of the technology.

The research, published online in Stem Cell Research, suggests that encapsulated hESC-derived insulin-producing cells may be an effective and safe cell replacement therapy for insulin dependent-diabetes.

Our study critically evaluates some of the potential pitfalls of using stem cells to treat insulin dependent-diabetes, said Pamela Itkin-Ansari, PhD, assistant project scientist in the UC San Diego Department of Pediatrics and adjunct assistant professor in Development, Aging and Regenerative program at Sanford-Burnham.

We have shown that encapsulated hESC-derived insulin-producing cells are able to produce insulin in response to elevated glucose without an increase in the mass or their escape from the capsule, said Itkin-Ansari. These results are important because it means that the encapsulated cells are both fully functional and retrievable.

Previous attempts to replace insulin producing cells, called beta cells, have met with significant challenges. For example, researchers have tried treating diabetics with mature beta cells, but because these cells are fragile and scarce, the method is fraught with problems. Moreover, since the cells come from organ donors, they may be recognized as foreign by the recipients immune system requiring patients to take immunosuppressive drugs to prevent their immune system from attacking the donors cells, ultimately leaving patients vulnerable to infections, tumors and other adverse events.

Encapsulation technology was developed to protect donor cells from exposure to the immune system and has proven extremely successful in preclinical studies.

Itkin-Ansari and her research team previously made an important contribution to the encapsulation approach by showing that pancreatic islet progenitor cells are an optimal cell type for encapsulation. They found that progenitor cells were more robust than mature beta cells to encapsulate, and while encapsulated, they matured into insulin-producing cells that secreted insulin only when needed.

In the study, Itkin-Ansari and her team used bioluminescent imaging to determine if encapsulated cells stay in the capsule after implantation.

Read more here:
Stem Cell-Derived Beta Cells Under Skin Replace Insulin

GM field trials: Regulator proposes but most states decline

Posted on by

The Genetic Engineering Approval Committee (GEAC) has approved field trials for 11 crop varieties but that clears only the first hurdle in the way of genetically-modified crops. Another major hitch could come from state governments, most of which do not seem to be in a mood to give their go-ahead anytime soon.

A survey conducted by Business Standard reveals that a majority of the countrys states are still firmly against the move, while a few are open to considering only conditionally. Some others are either neutral or might take a decision after the Lok Sabha elections.

According to GEAC officials, maize, mustard and rice are among the crops that have got approval for trials, but the states that are major producers of these crops remain opposed.

A piece of good news, though, has come from Maharashtra and Punjab, two of the largest agricultural states, which have favoured field trials for GM crops.

Officials say the use of high-yield GM crops could prove beneficial, given the growing demand for food grains, vegetables and oil seeds. But apprehensions of health hazard on the use of such seeds for consumable agricultural commodities seem to be playing a spoilsport. India had suspended field trials of these crops a few years ago but the GEAC approval last week for 11 varieties brought the issue back in the limelight.

The environment & forests ministry had in July 2011 made it mandatory for companies, institutes and research bodies to get no-objection certificates from states concerned before conducting trials. Also, GEAC analyses the sites for these trials on several parameters, including whether these are located too close to sanctuaries or water bodies.

Andhra Pradesh is home to several seed companies and BT Cotton was first introduced there. However, the state remains undecided on allowing field trials for GM crops. A decision on this will have to wait for the impending division of the state and formation of new governments. A technical committee is studying the issue.

Gujarat and Karnataka have not opposed the trials yet. The two are said to take a call only after the Lok Sabha elections. Major southern states like Tamil Nadu and Kerala, on the other hand, are against GM crops and unwilling to permit field trials. While Madhya Pradesh opposes field trials as a policy, Chhattisgarh might support if the Centre takes it on board. Punjab is open to field trials for maize, while Haryana is undecided.

The Maharashtra government has issued no-objection certificates to 28 applications for GM crop trials to seven private companies and the Nagpur-based Central Institute of Cotton Research.

Most of the 28 strains cleared for trials are of wheat, rice, maize and cotton. It will be Haryanas Bayer Bio Science for rice, Dow Agro Sciences, Pioneer Overseas Corporation and Syngenta Bio Sciences for maize, and Maharashtra Hybrid Seeds for wheat.

Read this article:
GM field trials: Regulator proposes but most states decline

New method yields potent, renewable human stem cells with promising therapeutic properties

Posted on by

PUBLIC RELEASE DATE:

25-Mar-2014

Contact: Vicki Cohn vcohn@liebertpub.com 914-740-2100 x2156 Mary Ann Liebert, Inc./Genetic Engineering News

New Rochelle, NY, March 24, 2014The curative and therapeutic potential of mesenchymal stem cells (MSCs) offers much promise, as these multipotent cells are currently being tested in more than 300 clinical trials in a range of diseases. A new, easier, and more reliable way to make large quantities of highly potent MSCs could accelerate progress toward their use in regenerative medicine, as described in an article in Stem Cells and Development, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Stem Cells and Development website.

Robert Lanza, MD and colleagues from Advanced Cell Technology (Marlborough, MA) and the David Geffen School of Medicine, UCLA (Los Angeles, CA), developed an innovative method for deriving MSCs from human embryonic stem cells (hESCs) through the use of a developmental precursor called the hemangioblast. They describe the technique and evidence of therapeutic efficacy using the hESC-MSCs to treat mouse models of lupus erythematosus and uveitis in the article "Mesenchymal Stem Cell Population Derived from Human Pluripotent Stem Cells Displays Potent Immunomodulatory and Therapeutic Properties."

"This new population of hESC-derived MSCs has a 30,000-fold greater proliferative capacity than bone marrow-derived MSCs," says Dr. Lanza, Chief Scientific Officer, Advanced Cell Technology. "In addition to being easy to derive in very large numbers, they are more youthful and live much longer." Dr. Lanza is Editor-in-Chief of BioResearch Open Access, a peer-reviewed open access journal from Mary Ann Liebert, Inc., publishers that provides a rapid-publication forum for a broad range of scientific topics.

###

About the Journal

Stem Cells and Development is an authoritative peer-reviewed journal published 24 times per year online with Open Access options and in print. Led by Editor-in-Chief Graham C. Parker, PhD, the Journal is dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. Complete tables of content and a sample issue may be viewed on the Stem Cells and Development website.

About the Publisher

Read the rest here:
New method yields potent, renewable human stem cells with promising therapeutic properties

Hundreds of students participate in science fair at SIU

Posted on by

Exclusive: Photos from Inside Anthony Sowell's Home Inside Look: Exclusives Photos Paint Disturbing Scene Inside Home of Anthony Sowell

Updated: Saturday, May 1 2010 11:19 AM EDT2010-05-01 16:19:26 GMT

GRAPHIC PICTURES: CLEVELAND, OH (WOIO) - It was one of the most gruesome sights in Cleveland crime history.

Updated: Tuesday, March 25 2014 5:29 PM EDT2014-03-25 21:29:47 GMT

Sunnie Kahle is 8 years old. She has short hair and a huge heart, and as far as her grandparents are concerned, she is a completely normal little girl.

Sunnie Kahle is 8 years old. She has short hair and a huge heart, and as far as her grandparents are concerned, she is a completely normal little girl.

The Missouri Highway Patrol says two drivers were killed in a head-on crash when one of them drove north in the southbound lanes of a highway south of St. Louis.

The Missouri Highway Patrol says two drivers were killed in a head-on crash when one of them drove north in the southbound lanes of a highway south of St. Louis.

Updated: Tuesday, March 25 2014 4:16 PM EDT2014-03-25 20:16:11 GMT

A Phoenix couple faces child abuse charges for neglecting to feed their 9-month-old baby who weighed 7 pounds when he was seen by medical staff, police said. Ryan Morris, 32, told police the baby had

More:
Hundreds of students participate in science fair at SIU